These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 11673833)
1. Abnormal nucleotide repeat sequence in the TGF-betaRII gene in hepatocellular carcinoma and in uninvolved liver tissue. Enomoto A; Esumi M; Yamashita K; Takagi K; Takano S; Iwai S J Pathol; 2001 Oct; 195(3):349-54. PubMed ID: 11673833 [TBL] [Abstract][Full Text] [Related]
2. Clinicopathological significance of altered loci of replication error and microsatellite instability-associated mutations in gastric cancer. Wu MS; Lee CW; Shun CT; Wang HP; Lee WJ; Sheu JC; Lin JT Cancer Res; 1998 Apr; 58(7):1494-7. PubMed ID: 9537253 [TBL] [Abstract][Full Text] [Related]
3. Gastric carcinomas with microsatellite instability: clinical features and mutations to the TGF-beta type II receptor, IGFII receptor, and BAX genes. Iacopetta BJ; Soong R; House AK; Hamelin R J Pathol; 1999 Mar; 187(4):428-32. PubMed ID: 10398102 [TBL] [Abstract][Full Text] [Related]
4. Lack of frameshift mutations at coding mononucleotide repeats in hepatocellular carcinoma in Japanese patients. Saeki A; Tamura S; Ito N; Kiso S; Matsuda Y; Yabuuchi I; Kawata S; Matsuzawa Y Cancer; 2000 Mar; 88(5):1025-9. PubMed ID: 10699890 [TBL] [Abstract][Full Text] [Related]
5. Accumulated frameshift mutations at coding nucleotide repeats during the progression of gastric carcinoma with microsatellite instability. Kim JJ; Baek MJ; Kim L; Kim NG; Lee YC; Song SY; Noh SH; Kim H Lab Invest; 1999 Sep; 79(9):1113-20. PubMed ID: 10496529 [TBL] [Abstract][Full Text] [Related]
6. Microsatellite instability, Epstein-Barr virus, mutation of type II transforming growth factor beta receptor and BAX in gastric carcinomas in Hong Kong Chinese. Leung SY; Yuen ST; Chung LP; Chu KM; Wong MP; Branicki FJ; Ho JC Br J Cancer; 1999 Feb; 79(3-4):582-8. PubMed ID: 10027334 [TBL] [Abstract][Full Text] [Related]
7. Microsatellite instability is uncommon in breast cancer. Anbazhagan R; Fujii H; Gabrielson E Clin Cancer Res; 1999 Apr; 5(4):839-44. PubMed ID: 10213220 [TBL] [Abstract][Full Text] [Related]
8. Analysis of transforming growth factor (TGF)-alpha/epidermal growth factor receptor, hepatocyte growth Factor/c-met,TGF-beta receptor type II, and p53 expression in human hepatocellular carcinomas. Kiss A; Wang NJ; Xie JP; Thorgeirsson SS Clin Cancer Res; 1997 Jul; 3(7):1059-66. PubMed ID: 9815784 [TBL] [Abstract][Full Text] [Related]
10. TGF-betaRII, BAX, IGFIIR, caspase-5, hMSH3 and hMSH6 alterations are not associated with microsatellite instability or p53 mutations in invasive urothelial carcinoma of the urinary bladder. Saetta AA; Korkolopoulou P; Karlou M; Levidou G; Goudopoulou A; Thymara I; Stamatelli A; Tzivras M; Michalopoulos NV; Thomas-Tsagli E; Patsouris E Pathology; 2007 Aug; 39(4):425-32. PubMed ID: 17676485 [TBL] [Abstract][Full Text] [Related]
11. A dominant negative mutation of transforming growth factor-beta receptor type II gene in microsatellite stable oesophageal carcinoma. Tanaka S; Mori M; Mafune K; Ohno S; Sugimachi K Br J Cancer; 2000 May; 82(9):1557-60. PubMed ID: 10789724 [TBL] [Abstract][Full Text] [Related]
12. Microsatellite instability in European hepatocellular carcinoma. Salvucci M; Lemoine A; Saffroy R; Azoulay D; Lepère B; Gaillard S; Bismuth H; Reynès M; Debuire B Oncogene; 1999 Jan; 18(1):181-7. PubMed ID: 9926933 [TBL] [Abstract][Full Text] [Related]
13. Mutation analysis of the transforming growth factor-beta type II receptor in human cell lines resistant to growth inhibition by transforming growth factor-beta. Vincent F; Nagashima M; Takenoshita S; Khan MA; Gemma A; Hagiwara K; Bennett WP Oncogene; 1997 Jul; 15(1):117-22. PubMed ID: 9233784 [TBL] [Abstract][Full Text] [Related]
14. The clinicopathological features of gastric carcinomas with microsatellite instability may be mediated by mutations of different "target genes": a study of the TGFbeta RII, IGFII R, and BAX genes. Oliveira C; Seruca R; Seixas M; Sobrinho-Simões M Am J Pathol; 1998 Oct; 153(4):1211-9. PubMed ID: 9777952 [TBL] [Abstract][Full Text] [Related]
15. Alterations of transforming growth factor-beta 1 receptor type II occur in ulcerative colitis-associated carcinomas, sporadic colorectal neoplasms, and esophageal carcinomas, but not in gastric neoplasms. Souza RF; Garrigue-Antar L; Lei J; Yin J; Appel R; Vellucci VF; Zou TT; Zhou X; Wang S; Rhyu MG; Cymes K; Chan O; Park WS; Krasna MJ; Greenwald BD; Cottrell J; Abraham JM; Simms L; Leggett B; Young J; Harpaz N; Reiss M; Meltzer SJ Hum Cell; 1996 Sep; 9(3):229-36. PubMed ID: 9183654 [TBL] [Abstract][Full Text] [Related]
16. Quantitative analysis of apoptosis-related gene expression in hepatocellular carcinoma. Ikeguchi M; Hirooka Y; Kaibara N Cancer; 2002 Nov; 95(9):1938-45. PubMed ID: 12404288 [TBL] [Abstract][Full Text] [Related]
17. Transforming growth factor-beta receptors and mannose 6-phosphate/insulin-like growth factor-II receptor expression in human hepatocellular carcinoma. Sue SR; Chari RS; Kong FM; Mills JJ; Fine RL; Jirtle RL; Meyers WC Ann Surg; 1995 Aug; 222(2):171-8. PubMed ID: 7639583 [TBL] [Abstract][Full Text] [Related]
18. A transforming growth factor beta type II receptor gene mutation common in sporadic cecum cancer with microsatellite instability. Togo G; Toda N; Kanai F; Kato N; Shiratori Y; Kishi K; Imazeki F; Makuuchi M; Omata M Cancer Res; 1996 Dec; 56(24):5620-3. PubMed ID: 8971166 [TBL] [Abstract][Full Text] [Related]
19. A transforming growth factor beta receptor type II gene mutation common in colon and gastric but rare in endometrial cancers with microsatellite instability. Myeroff LL; Parsons R; Kim SJ; Hedrick L; Cho KR; Orth K; Mathis M; Kinzler KW; Lutterbaugh J; Park K Cancer Res; 1995 Dec; 55(23):5545-7. PubMed ID: 7585631 [TBL] [Abstract][Full Text] [Related]
20. Alterations of BAT-26 identify a subset of gastric cancer with distinct clinicopathologic features and better postoperative prognosis. Wu MS; Lee CW; Sheu JC; Shun CT; Wang HP; Hong RL; Lee WJ; Lin JT Hepatogastroenterology; 2002; 49(43):285-9. PubMed ID: 11941977 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]